William E Fantegrossi

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Molecular Docking

Randomized Controlled Trial

Bipolar Disorder

Intimate Partner Violence

Top Venues

The Journal of pharmacology and experimental therapeutics

Pharmacology research & perspectives

Psychopharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Hannah E Shaw, Dylan R Patel, Brenda M Gannon, Lauren R Fitzgerald, Theresa M Carbonaro, Chad R Johnson, William E Fantegrossi
Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents. The Journal of pharmacology and experimental therapeutics 390 (1) (2024)
Hannah E Shaw, Dylan R Patel, Brenda M Gannon, Lauren R Fitzgerald, Theresa M Carbonaro, Chad R Johnson, William E Fantegrossi
Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents. The Journal of pharmacology and experimental therapeutics 390 (1) (2024)
Hannah E Shaw, Dylan R Patel, Brenda M Gannon, Lauren R Fitzgerald, Theresa M Carbonaro, Chad R Johnson, William E Fantegrossi
Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents. The Journal of pharmacology and experimental therapeutics 390 (1) (2024)
Hannah E Shaw, Dylan R Patel, Brenda M Gannon, Lauren R Fitzgerald, Theresa M Carbonaro, Chad R Johnson, William E Fantegrossi
Phencyclidine-like abuse liability and psychosis-like neurocognitive effects of novel arylcyclohexylamine drugs of abuse in rodents . The Journal of pharmacology and experimental therapeutics (2024)
Hannah E Shaw, Dylan R Patel, Brenda M Gannon, Lauren R Fitzgerald, Theresa M Carbonaro, Chad R Johnson, William E Fantegrossi
Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents. The Journal of pharmacology and experimental therapeutics 390 (1) (2024)
William E Fantegrossi, Brenda M Gannon
A "Furious" Effort to Develop Novel 3,4-Methylenedioxymethamphetamine-Like Therapeutics. The Journal of pharmacology and experimental therapeutics 391 (1) (2024)
Catheryn D Wilson, Fang Zheng, William E Fantegrossi
Convulsant doses of abused synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA and JWH-018 do not elicit electroencephalographic (EEG) seizures in male mice. Psychopharmacology 239 (10) (2022)
Sabrina Jones, Azure L Yarbrough, William E Fantegrossi, Paul L Prather, John M Bush, Anna Radominska-Pandya, Ryoichi Fujiwara
Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135). Pharmacology research & perspectives 8 (1) (2020)
Jai Shankar K Yadlapalli, Shoban Babu Bommagani, Ryan D Mahelona, Anqi Wan, Brenda M Gannon, Narsimha R Penthala, Maxim Dobretsov, Peter A Crooks, William E Fantegrossi
Evaluation of morphine-like effects of the mixed mu/delta agonist morphine-6-O-sulfate in rats: Drug discrimination and physical dependence. Pharmacology research & perspectives 6 (4) (2018)